The therapy shows efficacy in improving diarrhea, abdominal pain in GLP-1, GLP-1/GIP-treated patients with diabetes and/or obesity in a small study.
PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit shares new consensus statements for the diagnosis and ...
Effect of neoadjuvant therapy pathway (NATP) for pancreatic cancer on overall patient outcomes. This is an ASCO Meeting Abstract from the 2023 ASCO Gastrointestinal Cancers Symposium. This abstract ...
A research study recently published in the American Journal of Gastroenterology explains the role of pancreatic enzyme therapy (PERT) in reducing the frequency of acute pancreatitis (AP) in children ...
Pancreatic enzyme replacement therapy can help you effectively manage the symptoms of exocrine pancreatic insufficiency. You can also do your part to make sure your treatment is even more successful.
Nearly all UK pharmacies are experiencing severe “challenges” supplying pancreatic enzyme replacement therapy (PERT), the National Pharmacy Association (NPA) warned. A sample survey by the association ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results